Clinical Trials
21 trialsNCT07476287 2026-06-04
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Pfizer
Phase 2 Recruiting
NCT05834413 2026-05-13
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
Shanghai University of Traditional Chinese Medicine
Phase NA Recruiting
NCT07258147 2026-05-05
Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases
Sichuan University
Phase 2 Not yet recruiting
NCT07549061 2026-04-29
Vebreltinib Plus Chemotherapy as First-line Treatment for MET-overexpressing NSCLC
Shanghai Chest Hospital
Phase 2 Not yet recruiting
NCT05633602 2026-04-17
Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
SWOG Cancer Research Network
Phase 3 Active not recruiting
NCT07288034 2026-04-15
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
City of Hope Medical Center
Phase 2 Recruiting
NCT03939481 2026-04-13
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
SWOG Cancer Research Network
Active not recruiting
NCT06538038 2026-03-27
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Recruiting
NCT05143970 2026-03-20
CHANCES
Institut Paoli-Calmettes
Phase 1 Recruiting
NCT07472478 2026-03-16
GIVEN
Guangdong Provincial People's Hospital
Phase 2 Not yet recruiting
NCT04798664 2026-02-25
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT07398937 2026-02-10
ECTOP-1036
Fudan University
Phase 2 Recruiting
NCT06018376 2026-02-06
LUDICAS
Fundación GECP
Completed
NCT04151940 2026-01-14
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
University of Washington
Phase NA Recruiting
NCT06877299 2026-01-02
Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage â…¡A-â…¢B Non-small Cell Lung Cancer
Sichuan University
Phase 2 Recruiting
NCT07256002 2025-12-01
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Active not recruiting
NCT06228326 2025-10-24
KYANITE-1
Krystal Biotech, Inc.
Phase 1/2 Recruiting
NCT06784791 2025-08-29
NEOpredict-EGF
University Hospital, Essen
Phase 2 Recruiting
NCT07135882 2025-08-22
PRIME-Lung
Trans Tasman Radiation Oncology Group
Phase 3 Not yet recruiting
NCT02327078 2025-08-14
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Phase 1/2 Completed
NCT07076836 2025-07-22
Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
West China Hospital
Phase NA Not yet recruiting